Machine Learning to Refine Selection Criteria of PostOperative Radiotherapy for Resectable Stage III-N2 NonSmall Cell Lung Cancer

被引：0
|
作者：
Zarinshenas, R. [1 ]
Ladbury, C. J. [1 ]
Mcgee, H. M. [1 ]
Raz, D. [2 ]
Erhunmwunsee, L. [2 ,3 ]
Pathak, R. [4 ]
Glaser, S. M. [1 ]
Salgia, R. [4 ]
Williams, T. M. [1 ]
Amini, A. [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Radiat Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Surg, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Populat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2893
引用
收藏
页码：E400 / E400
页数：1
相关论文
共 50 条
  • [41] Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung cancer patients
    Yang, Jie
    Jiang, Chao
    Wang, Yue
    Qiu, Rong
    Su, Jingwei
    Liu, Changjiang
    Jing, Li
    JOURNAL OF THORACIC DISEASE, 2023, 15 (03) : 1426 - 1432
  • [42] A prospective randomized study of adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Zheng Shi Ying
    Jiang Dong
    Li Hong
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S518 - S518
  • [43] Systemic Inflammation-Immune Status Predicts Survival in Stage III-N2 Non-Small Cell Lung Cancer
    Wang, Jianyang
    Hui, Zhouguang
    Men, Yu
    Kang, Jingjing
    Sun, Xin
    Deng, Lei
    Zhai, Yirui
    Wang, Wenqing
    Bi, Nan
    Liang, Jun
    Lv, Jima
    Zhou, Zongmei
    Feng, Qinfu
    Xiao, Zefen
    Chen, Dongfu
    Wang, Luhua
    Zhao, Jun
    ANNALS OF THORACIC SURGERY, 2019, 108 (06): : 1701 - 1709
  • [44] PREOPERATIVE CONCOMITANT CISPLATIN VP16 AND RADIOTHERAPY IN STAGE-III NONSMALL CELL LUNG-CANCER
    PALAZZI, M
    CATALDO, I
    GRAMAGLIA, A
    DETOMA, D
    MILANI, F
    RAVASI, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03): : 621 - 625
  • [45] CARBOPLATIN, ETOPOSIDE, AND RADIOTHERAPY, FOLLOWED BY SURGERY, FOR THE TREATMENT OF MARGINALLY RESECTABLE NONSMALL CELL LUNG-CANCER
    DEUTSCH, MA
    LEOPOLD, KA
    CRAWFORD, J
    WOLFE, W
    FOSTER, W
    BLACKWELL, S
    YOST, R
    CANCER TREATMENT REVIEWS, 1993, 19 : 53 - 62
  • [46] Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non - small cell lung cancer
    Kumar, Arvind
    Srinivasan, Deepti
    Potter, Alexandra L.
    Mathey-Andrews, Camille
    Lanuti, Michael
    Martin, Linda W.
    Yang, Chi-Fu Jeffrey
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (06): : 1906 - 1907
  • [47] Combined Treatment of Nonsmall Cell Lung Cancer NSCLC Stage III With Intensity-Modulated RT Radiotherapy and Cetuximab
    Jensen, Alexandra D.
    Muenter, Marc W.
    Bischoff, Helge G.
    Haselmann, Renate
    Haberkorn, Uwe
    Huber, Peter E.
    Thomas, Michael
    Debus, Juergen
    Herfarth, Klaus K.
    CANCER, 2011, 117 (13) : 2986 - 2994
  • [48] The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer
    Ishida, Masayuki
    Mimae, Takahiro
    Kamigaichi, Atsushi
    Kawamoto, Nobutaka
    Tsubokawa, Norifumi
    Miyata, Yoshihiro
    Okada, Morihito
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5055 - 5063
  • [49] Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Patients with Stage III-N2 Non-small Cell Lung Cancer
    Liu, Junhong
    Shi, Zhihua
    Cao, Bingji
    Wang, Zhe
    Zhang, Nan
    Liu, Junfeng
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5028 - 5037
  • [50] DO PATIENTS COMMENCING MULTI-MODALITY TREATMENT FOR STAGE III-N2 LUNG CANCER COMPLETE THEIR TREATMENT?
    Campbell, C.
    Salman, R.
    Morris, J.
    Awni, H.
    Paramasivam, E.
    Kennedy, M. P. T.
    THORAX, 2021, 76 : A97 - A97
12345